Morningside Venture Investments Ltd - 31 Dec 2022 Form 5 Insider Report for Amylyx Pharmaceuticals, Inc. (AMLX)

Role
10%+ Owner
Signature
/s/ Frances Anne Elizabeth Richard, Director
Issuer symbol
AMLX
Transactions as of
31 Dec 2022
Net transactions value
$0
Form type
5
Filing time
11 Jan 2023, 15:07:27 UTC
Previous filing
05 Jan 2023
Next filing
09 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMLX Common Stock Gift $0 -170,000 -1.9% $0.000000 8,887,264 12 Sep 2022 Direct
transaction AMLX Common Stock Gift $0 -340,000 -3.8% $0.000000 8,547,264 12 Sep 2022 Direct
transaction AMLX Common Stock Gift $0 -33,333 -0.39% $0.000000 8,513,931 20 Sep 2022 Direct
transaction AMLX Common Stock Gift $0 -833,333 -9.8% $0.000000 7,680,598 23 Sep 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.